Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,741.00
Bid: 1,740.50
Ask: 1,741.00
Change: -5.50 (-0.31%)
Spread: 0.50 (0.029%)
Open: 1,748.50
High: 1,752.50
Low: 1,736.50
Prev. Close: 1,746.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET EARLY CALL: Stocks called higher; pound below USD1.20

Thu, 02nd Mar 2023 06:56

(Alliance News) - Stocks in London are set to open higher on Thursday, ahead of a eurozone inflation reading.

IG says futures indicate the FTSE 100 index of large-caps to open up 15.5 points, 0.2%, at 7,930.43 on Thursday. The index closed up 38.65 points, or 0.5% at 7,914.93 on Wednesday.

"European markets got off to a broadly negative start to the month yesterday, except for the FTSE 100, which managed to finish the session higher, due to a decent performance from the basic resource sector on optimism over the China reopening story," explained CMC Markets' Michael Hewson.

The pound softened further against the dollar, having dropped below USD1.20 as sterling's recent rally lost steam following cautious words from Bank of England Governor Andrew Bailey.

In a speech on Wednesday, Bailey said "nothing is decided" as far as interest rates go, and markets shouldn't assume more interest rate hikes are ahead.

Sterling was quoted at USD1.1987 early Thursday, slightly lower than USD1.1994 at the London equities close on Wednesday.

The day could be consequential for the euro, with a eurozone inflation reading due in at 1000 GMT.

Recent data from France, Spain and Germany have shown an upward trend to inflation, prompting fears of further hawkishness from the European Central Bank.

The euro traded at USD1.0640, down from USD1.0663. Against the yen, the dollar was quoted at JPY136.64, up versus JPY136.15.

In the US on Wednesday, Wall Street ended mixed, with the Dow Jones Industrial Average ending marginally higher, the S&P 500 up 0.5% and the Nasdaq Composite up 0.7%.

Late Wednesday, GSK said a US Food & Drug Administration committee voted unanimously to support the effectiveness of its respiratory syncytial virus vaccine, with the majority also supporting its safety.

It now expects a decision on US approval by May 3. GSK said the vaccine could potentially be the first approved for older adults.

In Tokyo on Thursday, the Nikkei 225 index closed down 0.1%. The Shanghai Composite was down 0.1%, while the Hang Seng index in Hong Kong was down 0.9%. The S&P/ASX 200 in Sydney closed up 0.1%.

Gold was quoted at USD1,833.06 an ounce early Thursday in London, lower than USD1,838.50 on Wednesday. Brent oil was trading at USD84.30 a barrel, higher than USD83.78.

In Thursday's UK corporate calendar, there are full-year results from London Stock Exchange Group, ITV, Haleon and National Express.

In the economic calendar, the EU will publish unemployment and inflation data at 1000 GMT. The US will publish its weekly unemployment claims report at 1330 GMT.

By Elizabeth Winter, Alliance News senior markets reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
Today 09:23

LONDON BROKER RATINGS: Jefferies and UBS cut Anglo American

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and on Wednesday:

Read more
Today 07:40

LONDON BRIEFING: Dr Martens cuts payout as profit plummets

(Alliance News) - Stocks in London are called to open lower on Thursday, with investors nervous ahead of Friday's US inflation print.

Read more
27 May 2024 06:00

US, European nations consider vaccinating workers exposed to bird flu

CHICAGO/LONDON, May 27 (Reuters) - The United States and Europe are taking steps to acquire or manufacture H5N1 bird flu vaccines that could be used to protect at-risk poultry and dairy workers, veterinarians and lab technicians, government officials said, moves influenza experts say could curb the threat of a pandemic.

Read more
24 May 2024 15:19

London close: Stocks mixed after disappointing retail sales data

(Sharecast News) - London stocks closed with mixed results on Friday, influenced by earlier declines in the US and Asian markets, as investors reacted to a larger-than-expected drop in UK retail sales.

Read more
24 May 2024 08:55

LONDON MARKET OPEN: FTSE 100 falls; retail sales plunge in April

(Alliance News) - Stock prices in London opened lower on Friday, with sentiment hurt across the globe.

Read more
24 May 2024 08:36

TOP NEWS: GSK celebrates Illinois jury verdict in Valadez case

(Alliance News) - GSK PLC on Friday welcomed the jury verdict in the Valadez case in Illinois state court, which found in GSK's favour in the first Zantac case to go to trial.

Read more
24 May 2024 07:52

LONDON BRIEFING: UK retail sales fall amid wet April; Co-Op Bank deal

(Alliance News) - Stocks are called to open lower on Friday, following New York lower, as hopes of interest rate cuts have come into question.

Read more
24 May 2024 07:30

Jury rules in favour of GSK in Zantac trial

(Sharecast News) - A court in Illinois has ruled in favour of GSK in the first Zantac case to go to trial, the UK drugs giant confirmed on Friday.

Read more
23 May 2024 19:21

Zantac not a cause of woman’s cancer, jury says in first trial over drug

CHICAGO, May 23 (Reuters) - A jury in Chicago on Thursday rejected an Illinois woman’s claim that the now discontinued heartburn drug Zantac caused her colon cancer, in the first trial out of thousands of lawsuits making similar allegations.

Read more
22 May 2024 22:59

What to know about bird flu in dairy cows and the risk to humans

CHICAGO, May 22 (Reuters) -

Read more
21 May 2024 11:23

AstraZeneca aims for $80 bln in total revenue by 2030

Sees $80 bln in 2030 revenue by 2030

*

Read more
21 May 2024 08:49

GSK's depemokimab asthma treatment meets endpoints in latest trials

(Alliance News) - GSK PLC on Tuesday announced positive results from trials of depemokimab, an "ultra-long-acting biologic" that could simplify treatment options for patients with severe asthma.

Read more
21 May 2024 07:21

GSK reports promising results from asthma treatment trials

(Sharecast News) - GSK announced promising results from phase three clinical trials evaluating the efficacy and safety of depemokimab in treating severe asthma with type 2 inflammation on Tuesday.

Read more
20 May 2024 16:11

IN BRIEF: GSK executive buys GBP20,026 worth shares

GSK PLC - London-based pharmaceuticals firm - Senior Vice President, Global Communications & Chief Executive Office, Sally Jackson, buys 1,120 shares at 1,788 pence each. Worth total GBP20,026.

Read more
17 May 2024 17:38

London's FTSE nudges lower for week after record run

Haleon falls after GSK offloads remaining stake

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.